Published in Pediatr Pulmonol on April 25, 2017
Consensus-based method for risk adjustment for surgery for congenital heart disease. J Thorac Cardiovasc Surg (2002) 6.92
Prevention of chronic Pseudomonas aeruginosa colonisation in cystic fibrosis by early treatment. Lancet (1991) 3.26
Mucoid Pseudomonas aeruginosa is a marker of poor survival in cystic fibrosis. Pediatr Pulmonol (1992) 3.00
Multicenter, double-blind, randomized, placebo-controlled trial assessing the efficacy and safety of proton pump inhibitor lansoprazole in infants with symptoms of gastroesophageal reflux disease. J Pediatr (2008) 2.82
Effectiveness of fundoplication at the time of gastrostomy in infants with neurological impairment. JAMA Pediatr (2013) 2.81
Acceleration of lung disease in children with cystic fibrosis after Pseudomonas aeruginosa acquisition. Pediatr Pulmonol (2001) 2.59
Gender differences in cystic fibrosis: Pseudomonas aeruginosa infection. J Clin Epidemiol (1995) 2.11
Significant microbiological effect of inhaled tobramycin in young children with cystic fibrosis. Am J Respir Crit Care Med (2002) 1.70
Therapy with gastric acidity inhibitors increases the risk of acute gastroenteritis and community-acquired pneumonia in children. Pediatrics (2006) 1.51
Assessing Differences in Mortality Rates and Risk Factors Between Hispanic and Non-Hispanic Patients With Cystic Fibrosis in California. Chest (2016) 1.50
Effects of pseudomonas aeruginosa colonization on lung function and anthropometric variables in children with cystic fibrosis. Pediatr Pulmonol (1995) 1.44
Predictors of clinical outcomes and hospital resource use of children after tracheotomy. Pediatrics (2009) 1.40
Tracheotomy in pediatric patients: a national perspective. Arch Otolaryngol Head Neck Surg (2003) 1.31
Placebo-controlled, double-blind, randomized study of aerosolized tobramycin for early treatment of Pseudomonas aeruginosa colonization in cystic fibrosis. Pediatr Pulmonol (1998) 1.21
Reflux related hospital admissions after fundoplication in children with neurological impairment: retrospective cohort study. BMJ (2009) 1.20
Acquisition and eradication of P. aeruginosa in young children with cystic fibrosis. Eur Respir J (2008) 1.18
Initial Pseudomonas aeruginosa treatment failure is associated with exacerbations in cystic fibrosis. Pediatr Pulmonol (2011) 1.10
Racial and ethnic disparities in post-operative mortality following congenital heart surgery. J Pediatr (2011) 1.09
Clinical outcomes after initial pseudomonas acquisition in cystic fibrosis. Pediatr Pulmonol (2014) 1.05
Patient characteristics associated with in-hospital mortality in children following tracheotomy. Arch Dis Child (2010) 1.04
Hospital charges of potentially preventable pediatric hospitalizations. Acad Pediatr (2012) 0.99
Eradication of early Pseudomonas infection in cystic fibrosis. Chron Respir Dis (2009) 0.93
Risk factors for lung function decline in a large cohort of young cystic fibrosis patients. Pediatr Pulmonol (2015) 0.86
Children and Young Adults Who Received Tracheostomies or Were Initiated on Long-Term Ventilation in PICUs. Pediatr Crit Care Med (2016) 0.82
Hospitalizations in children with preexisting tracheostomy: a national perspective. Laryngoscope (2014) 0.80
Pediatric Hospital Discharges to Home Health and Postacute Facility Care: A National Study. JAMA Pediatr (2016) 0.78
Description of Respiratory Microbiology of Children With Long-Term Tracheostomies. Respir Care (2015) 0.78
Emergency department use among children with tracheostomies: Avoidable visits. J Pediatr Rehabil Med (2015) 0.77
Care Variations and Outcomes for Children Hospitalized With Bacterial Tracheostomy-Associated Respiratory Infections. Hosp Pediatr (2017) 0.77